Ovarialkarzinom: Diagnostik und screening

B. Schmalfeldt; K. Seck

doi:10.1007/s00129-012-3109-3

Ovarialkarzinom: Diagnostik und screening

Translated title of the contribution: Ovarian cancer: Diagnostics and screening

B. Schmalfeldt
, K. Seck

Department of Gynecology

Technical University of Munich

Research output: Contribution to journal › Article › peer-review

3 Scopus citations

Abstract

Ovarian cancer is diagnosed usually in advanced stages. Until now, minimal progress has been achieved to detect ovarian cancer at a more curable early stage. There is no proof that routine screening for ovarian cancer in the general and high risk population with serum markers, sonograms or pelvic examinations decrease mortality. There is no recommendation for routine ovarian cancer screening.

Translated title of the contribution	Ovarian cancer: Diagnostics and screening
Original language	German
Pages (from-to)	531-535
Number of pages	5
Journal	Gynakologe
Volume	46
Issue number	8
DOIs	https://doi.org/10.1007/s00129-012-3109-3
State	Published - Aug 2013

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

10.1007/s00129-012-3109-3

Cite this

@article{55eb0568fe9847cf9efd2db184704480,

title = "Ovarialkarzinom: Diagnostik und screening",

abstract = "Ovarian cancer is diagnosed usually in advanced stages. Until now, minimal progress has been achieved to detect ovarian cancer at a more curable early stage. There is no proof that routine screening for ovarian cancer in the general and high risk population with serum markers, sonograms or pelvic examinations decrease mortality. There is no recommendation for routine ovarian cancer screening.",

keywords = "BRCA1 gene product, Diagnostic imaging, Early detection of cancer, Tumor markers, Vaginal ultrasound",

author = "B. Schmalfeldt and K. Seck",

year = "2013",

month = aug,

doi = "10.1007/s00129-012-3109-3",

language = "Deutsch",

volume = "46",

pages = "531--535",

journal = "Gynakologe",

issn = "0017-5994",

publisher = "Springer Medizin",

number = "8",

}

TY - JOUR

T1 - Ovarialkarzinom

T2 - Diagnostik und screening

AU - Schmalfeldt, B.

AU - Seck, K.

PY - 2013/8

Y1 - 2013/8

N2 - Ovarian cancer is diagnosed usually in advanced stages. Until now, minimal progress has been achieved to detect ovarian cancer at a more curable early stage. There is no proof that routine screening for ovarian cancer in the general and high risk population with serum markers, sonograms or pelvic examinations decrease mortality. There is no recommendation for routine ovarian cancer screening.

AB - Ovarian cancer is diagnosed usually in advanced stages. Until now, minimal progress has been achieved to detect ovarian cancer at a more curable early stage. There is no proof that routine screening for ovarian cancer in the general and high risk population with serum markers, sonograms or pelvic examinations decrease mortality. There is no recommendation for routine ovarian cancer screening.

KW - BRCA1 gene product

KW - Diagnostic imaging

KW - Early detection of cancer

KW - Tumor markers

KW - Vaginal ultrasound

UR - https://www.scopus.com/pages/publications/84890517085

U2 - 10.1007/s00129-012-3109-3

DO - 10.1007/s00129-012-3109-3

M3 - Artikel

AN - SCOPUS:84890517085

SN - 0017-5994

VL - 46

SP - 531

EP - 535

JO - Gynakologe

JF - Gynakologe

IS - 8

ER -

Ovarialkarzinom: Diagnostik und screening

Abstract

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this